Get reimbursed for COVID-19 testing and treatment of uninsured individuals.     Learn more »

Advancing the HRSA Strategy to Address Intimate Partner Violence Request for Information

Type of Notice:  Request for Information

Title:  Advancing the HRSA Strategy to Address Intimate Partner Violence Request for Information

Response Date:  Monday, December 9, 2019 by 11:59 p.m. Eastern Time.

Summary:  The Health Resources and Services Administration (HRSA) seeks information about how the agency could sustain activities described in the HRSA Strategy to Address Intimate Partner Violence, 2017-2020 and/or begin new initiatives to address intimate partner violence (IPV) in the communities served by HRSA programs.  HRSA seeks responses to the “Questions for Public Comment” section of this Request for Information (RFI).  These responses could inform HRSA’s decision making related to planning future initiatives among other purposes.

Dates:  Submit comments to the email listed in the “Response Format” section by 11:59 p.m. Eastern Time on Monday, December 9, 2019.

Response Format:  Responses to this RFI must be provided via email to and must reference “IPV RFI” in the title.  HRSA will not accept hard-copy responses or other formats.


HRSA’s Office of Women’s Health is soliciting public input to inform the next phase of the HRSA Strategy to Address Intimate Partner Violence, 2017-2020 (PDF - 429 KB).  HRSA’s intent is to conduct activities that will achieve a measurable impact in at least one of four priority areas:

  • training the health workforce,
  • developing partnerships,
  • increasing access to care, and
  • addressing gaps in knowledge.

We encourage input from a broad range of organizational and individual stakeholders, including health service delivery and other community-based organizations, health care providers, researchers, community members, patients, survivors, consumers, families, caregivers, advocates, and other interested parties.


Intimate partner violence (IPV) affects millions of individuals and families in the United States with as many as one in four women and one in ten men experiencing severe physical violence by an intimate partner during their lifetime.1 In response to this key public health issue, HRSA developed and implemented a three-year (2017-2020) agency-wide strategy to address IPV through its programs (PDF - 429 KB).  Leaders from all bureaus and offices collaborated to identify 27 activities centered on four priorities:

• training the health workforce,
• developing partnerships,
• increasing access to care, and
• addressing gaps in knowledge.

HRSA’s progress in implementing the Strategy’s 27 activities during Phase One (2017-2018) is summarized in a Progress Report (PDF - 3.2 MB). With the exception of the five activities described on page 9 of the report, the majority of the Strategy’s activities were implemented by integration into existing HRSA efforts (e.g., disseminating tools through existing communications channels, convening educational webinars, highlighting IPV during stakeholder meetings).

In addition to the funded activities described in the Strategy and the Progress Report (e.g., the Ryan White HIV/AIDS Program’s Part D supplemental awards and E2i initiative HRSA Exit Disclaimer), HRSA has begun several new activities to further address IPV as a critical social determinant of health.  For example, on July 26, 2019, HRSA’s Bureau of Primary Health Care (BPHC) published a Program Assistance Letter (PAL) announcing proposed changes for CY2020 Uniform Data System Reporting that includes the addition of international classification of diseases (ICD)-10 codes to capture human trafficking and IPV for the first time (PDF - 455 KB).  On September 16, 2019, BPHC also announced a FY 2020 Notice of Funding Opportunity (HRSA-20-022) seeking applications for National Health Center Training and Technical Assistance Partners (NTTAP) Cooperative Agreements. One of the NTTAP cooperative agreements will focus on providing training and technical assistance related to IPV and human trafficking for health centers nationwide (see pages 40-41).  HRSA plans to make the award on or around July 1, 2020.

Questions for Public Comment

  1. What are examples of concrete activities (including products and/or tools) with measurable impacts that HRSA could undertake to continue addressing IPV in the communities served by our programs?  Identify the potential target audiences and expected outcome(s). If available, please also include potential data sources or data collection opportunities associated with these outcomes.  Please prioritize your suggestions of activities.
  2. What challenges in IPV prevention, assessment, and response exist for:
    • health care providers and other paraprofessionals,
    • patients (including those groups that may be disproportionately impacted),
    • organizations (including those who work in partnership with health care service settings) and;
    • communities (including those that are geographically isolated and/or medically underserved)?
  3. What can HRSA do to address challenges identified in question 2?
  4. In addition to partners identified in the HRSA Strategy to Address IPV, are there other stakeholders HRSA could consult with to further inform future activities?  Please explain their role and what outcomes they could help facilitate.

Submitting Comments: 

Please submit comments via email to, and reference “IPV Strategy RFI” in the subject line.  If you provide comments to more than one question, please identify the specific RFI question to which each comment is directed. 

Information obtained as a result of this RFI may be used by HRSA and HHS for program planning and program decision making on a non-attribution basis.  Responses to this RFI may be made publicly available; therefore, respondents should not include any information that might be considered proprietary or confidential.

HRSA will not respond to any individual comments, except to clarify written responses.  Comments will be received through 11:59 p.m. Eastern Time on Monday, December 9, 2019.

Special Note to Commenters:

Whenever possible, respondents are asked to draw their responses from objective, empirical, and actionable evidence and to cite this evidence within their responses.

This RFI is issued solely for information and planning purposes; it does not constitute a Request for Proposal, applications, proposal abstracts, or quotations.  This RFI does not commit the Government to contract for any supplies or services or make a grant or cooperative agreement award.  Further, HRSA is not seeking proposals through this RFI and will not accept unsolicited proposals. Responders are advised that the U.S. Government will not pay for any information or administrative costs incurred in response to this RFI; all costs associated with responding to this RFI will be solely at the interested party’s expense.  Not responding to this RFI does not preclude participation in any future procurement or program, if conducted.  All submissions become Government property and will not be returned. Please note that HRSA will not respond to questions about potential policy issues related to this RFI.

1Smith SG, Zhang X, Basile KC, et al. National Intimate Partner and Sexual Violence Survey: 2015 Data Brief—Updated Release. Atlanta, GA: Division of Violence Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, US Department of Health and Human Services; 2018

Date Last Reviewed:  October 2019